Literature DB >> 33496750

von Willebrand disease: proposing definitions for future research.

Nathan T Connell1, Paula D James2, Romina Brignardello-Petersen3, Rezan Abdul-Kadir4, Barbara Ameer5,6, Alice Arapshian7, Susie Couper8, Jorge Di Paola9, Jeroen Eikenboom10, Nicolas Giraud11, Jean M Grow12, Sandra Haberichter13, Vicki Jacobs-Pratt14, Barbara A Konkle15,16, Peter Kouides17, Michael Laffan18, Michelle Lavin19, Frank W G Leebeek20, Claire McLintock21, Simon McRae22, Robert Montgomery23, Sarah H O'Brien24, James S O'Donnell19, Margareth C Ozelo25, Nikole Scappe26, Robert Sidonio27, Alberto Tosetto28, Angela C Weyand29, Mohamad A Kalot30, Nedaa Husainat30, Reem A Mustafa30, Veronica H Flood23.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33496750      PMCID： PMC7839375          DOI： 10.1182/bloodadvances.2020003620

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  32 in total

1.  Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis.

Authors:  Nicholas L Smith; Kenneth M Rice; Edwin G Bovill; Mary Cushman; Joshua C Bis; Barbara McKnight; Thomas Lumley; Nicole L Glazer; Astrid van Hylckama Vlieg; Weihong Tang; Abbas Dehghan; David P Strachan; Christopher J O'Donnell; Jerome I Rotter; Susan R Heckbert; Bruce M Psaty; Frits R Rosendaal
Journal:  Blood       Date:  2010-12-16       Impact factor: 22.113

2.  Visually estimated and calculated blood loss in vaginal and cesarean delivery.

Authors:  Irene Stafford; Gary A Dildy; Steven L Clark; Michael A Belfort
Journal:  Am J Obstet Gynecol       Date:  2008-07-17       Impact factor: 8.661

Review 3.  Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients.

Authors:  S Schulman; U Angerås; D Bergqvist; B Eriksson; M R Lassen; W Fisher
Journal:  J Thromb Haemost       Date:  2009-10-30       Impact factor: 5.824

4.  The prevalence of symptomatic von Willebrand disease in primary care practice.

Authors:  M Bowman; W M Hopman; D Rapson; D Lillicrap; P James
Journal:  J Thromb Haemost       Date:  2009-10-23       Impact factor: 5.824

5.  Practical aspects of DDAVP use in patients with von Willebrand Disease undergoing invasive procedures: a European survey.

Authors:  J Windyga; G Dolan; C Altisent; O Katsarou; M-F López Fernández; B Zülfikar
Journal:  Haemophilia       Date:  2015-07-24       Impact factor: 4.287

6.  Puerperal loss (lochia) in women with or without inherited bleeding disorders.

Authors:  Claudia Chi; Mira Bapir; Christine A Lee; Rezan A Kadir
Journal:  Am J Obstet Gynecol       Date:  2010-04-24       Impact factor: 8.661

7.  The role of prophylaxis in the management of von Willebrand disease: today and tomorrow.

Authors:  Thomas Abshire
Journal:  Thromb Res       Date:  2009-11       Impact factor: 3.944

8.  Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD.

Authors:  Giancarlo Castaman; Stefan Lethagen; Augusto B Federici; Alberto Tosetto; Anne Goodeve; Ulrich Budde; Javier Batlle; Dominique Meyer; Claudine Mazurier; Edith Fressinaud; Jenny Goudemand; Jeroen Eikenboom; Reinhard Schneppenheim; Jorgen Ingerslev; Zdena Vorlova; David Habart; Lars Holmberg; John Pasi; Frank Hill; Ian Peake; Francesco Rodeghiero
Journal:  Blood       Date:  2008-01-29       Impact factor: 22.113

9.  Epidemiological investigation of the prevalence of von Willebrand's disease.

Authors:  F Rodeghiero; G Castaman; E Dini
Journal:  Blood       Date:  1987-02       Impact factor: 22.113

10.  Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery.

Authors:  F Peyvandi; A Mamaev; J-D Wang; O Stasyshyn; M Timofeeva; N Curry; A R Cid; T T Yee; K Kavakli; G Castaman; A Sytkowski
Journal:  J Thromb Haemost       Date:  2018-12-20       Impact factor: 5.824
View more
  3 in total

Review 1.  Pregnancy in special populations: challenges and solutions practical aspects of managing von Willebrand disease in pregnancy.

Authors:  Ozlem Turan; Rezan Abdul Kadir
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 2.  Von Willebrand Disease: Current Status of Diagnosis and Management.

Authors:  Angela C Weyand; Veronica H Flood
Journal:  Hematol Oncol Clin North Am       Date:  2021-08-13       Impact factor: 3.722

Review 3.  Prophylactic management of patients with von Willebrand disease.

Authors:  Massimo Franchini; Omid Seidizadeh; Pier Mannuccio Mannucci
Journal:  Ther Adv Hematol       Date:  2021-12-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.